- CG Oncology, Inc.

QQQ $ 479.30 $ 2.47 (0.52 %)

DIA $ 386.46 $ -0.42 (-0.11 %)

SPY $ 542.65 $ 0.33 (0.06 %)

TLT $ 94.67 $ 0.79 (0.84 %)

GLD $ 215.76 $ 2.76 (1.3 %)

Previous Close

$ 34.66

Open

$ 35.05

Bid

$ 0.00 x 0

Ask

$ 34.74 x 200

Day's Range

$ 33.87 - $ 35.21

52 Week Range

$ 25.77 - $ 50.23

Volume

502,034

Average Volume

Market Cap

Beta (5Y Monthly)

$ 3.46

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na (nm)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
1	05-09-2024	03-31-2024	10-Q
2	03-26-2024	12-31-2023	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

why-science-applications-international-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Science Applications International Sha...
06/03/2024 17:56:53

stericycle-marinemax-agios-pharmaceuticals-and-other-big-stocks-moving-higher-on-monday

Stericycle, MarineMax, Agios Pharmaceutica...
06/03/2024 14:39:44

HC Wainwright & Co. Reiterates Buy on CG O...
05/28/2024 10:25:02

HC Wainwright & Co. analyst Andres Maldonado reiterates CG Oncology (NASDAQ:CGON) with a Buy and maintains $75 price tar...

CG Oncology To Present Final Results From ...
05/24/2024 12:08:50

Decoding 10 Analyst Evaluations For CG Onc...
05/14/2024 17:00:55

Goldman Sachs Upgrades CG Oncology to Buy,...
05/14/2024 12:41:31

Goldman Sachs analyst Corinne Johnson upgrades CG Oncology (NASDAQ:CGON) from Neutral to Buy and raises the price target fro...

Goldman Sachs Upgrades CG Oncology to Buy,...
05/13/2024 20:25:34

Goldman Sachs analyst Corinne Johnson upgrades CG Oncology (NASDAQ:CGON) from Neutral to Buy and announces $50 price target.

HC Wainwright & Co. Reiterates Buy on CG O...
05/10/2024 12:28:05

HC Wainwright & Co. analyst Andres Maldonado reiterates CG Oncology (NASDAQ:CGON) with a Buy and maintains $75 price tar...

CG Oncology Q1 EPS $(0.36) Up From $(3.22)...
05/09/2024 13:03:22

CG Oncology (NASDAQ:CGON) reported quarterly losses of $(0.36) per share. This is a 88.82 percent increase over losses of $(3.2...

Cantor Fitzgerald Reiterates Overweight on...
05/06/2024 13:57:45

Cantor Fitzgerald analyst Josh Schimmer reiterates CG Oncology (NASDAQ:CGON) with a Overweight and maintains $75 price target.

HC Wainwright & Co. Reiterates Buy on CG O...
05/06/2024 10:50:05

HC Wainwright & Co. analyst Andres Maldonado reiterates CG Oncology (NASDAQ:CGON) with a Buy and maintains $75 price tar...

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
05/03/2024 16:31:47

CG Oncology Announces Data From The Phase ...
05/03/2024 15:26:33

- Phase 3 BOND-003 study results showed sustained, durable complete responses over 12 months with novel investigational oncolyt...

amgen-posts-upbeat-results-joins-onespan-paylocity-holding-mercadolibre-and-other-big-stocks-moving-higher-on-friday

Amgen Posts Upbeat Results, Joins OneSpan,...
05/03/2024 14:15:59

Cantor Fitzgerald Reiterates Overweight on...
05/02/2024 16:02:04

Cantor Fitzgerald analyst Josh Schimmer reiterates CG Oncology (NASDAQ:CGON) with a Overweight and maintains $75 price target.

CG Oncology To Unveil Results On Cretostim...
04/24/2024 14:04:53

CG Oncology, Inc. (NASDAQ:CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a po...

HC Wainwright & Co. Reiterates Buy on CG O...
04/04/2024 10:11:51

HC Wainwright & Co. analyst Andres Maldonado reiterates CG Oncology (NASDAQ:CGON) with a Buy and maintains $75 price tar...

CG Oncology Announces First Patient Dosed ...
02/27/2024 13:04:40

- PIVOT-006 Phase 3 open-label trial of adjuvant cretostimogene is CG Oncology's earliest disease stage clinical trial for ...

Cantor Fitzgerald Initiates Coverage On CG...
02/20/2024 14:10:16

Cantor Fitzgerald analyst Josh Schimmer initiates coverage on CG Oncology (NASDAQ:CGON) with a Overweight rating and announc...

Goldman Sachs Initiates Coverage On CG Onc...
02/20/2024 10:33:22

Goldman Sachs analyst Corinne Johnson initiates coverage on CG Oncology (NASDAQ:CGON) with a Neutral rating and announces Pr...

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)

07/01/2024 Equinix, Inc. (EQIX)

07/02/2024 Intel Corporation (INTC)

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)

CGONCG Oncology, Inc.

Nasdaq cgoncology.com

$ 34.72 $ -0.15 (-0.43 %)

Friday, 14-Jun-2024 15:59:58 EDT